Ä¢¹½ÊÓÆµ

March 24, 2025
Ä¢¹½ÊÓÆµAdvises Regor Pharmaceuticals (USA) in $850 Million Oncology Transaction with Genentech

Ä¢¹½ÊÓÆµrepresented Regor Pharmaceuticals in its sale of next-generation CDK inhibitors for breast cancer treatment to Genentech (a Roche Group member) for an upfront payment of $850 million plus milestone payments. Ä¢¹½ÊÓÆµadvised on all aspects of the negotiation and transaction. We are proud to support impactful transactions driving pharmaceutical innovation.

read more
June 13, 2022
Ä¢¹½ÊÓÆµAdvises Agribusiness Client in SPAC Transaction Raising $45 Million

Ä¢¹½ÊÓÆµserved as securities counsel to Forafric Agro Holdings Limited, a leading agribusiness company specializing in wheat processing, in connection with its business combination with Globis Acquisition Corp., a special purpose acquisition company. Forafric raised $45 million in new capital. The combined ordinary shares and public warrants of the combined company, which will do business […]

read more
March 15, 2022
Ä¢¹½ÊÓÆµHosts Internet of Things CEO in Founder Spotlight Discussion

Ä¢¹½ÊÓÆµhosted a Founder Spotlight virtual chat with Jake Simon, Founder and CEO of ConnectedFresh, an Internet of Things food safety tech platform. Jake discussed several lessons and takeaways for other founders in attendance, including approaches to software development and operations, strategic partnerships, and building a team. Ä¢¹½ÊÓÆµhosts regular webinars and discussions for the […]

read more